Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 12, Issue 23, Pages 2911-2921Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161206777947588
Keywords
liver; transplantation; surgery; apoptosis; ischemia
Categories
Ask authors/readers for more resources
This review highlights recent advances in our understanding of intracellular mechanisms underlying programmed cell death in hepatic ischemia / reperfusion injury. A range of molecules have been tested with the intention to block the pathways of programmed cell death at different levels and to thereby enhance viability of the liver in surgical procedures including liver transplantation. Cellular death receptors, the mitochondrial pathway of apoptosis, p53, mitogen-activated protein kinases (MAPKs) and intracellular proteases all present potential targets for pharmaceutical agents to prevent ischemia induced cell death in the liver. Although evidence has been provided for effective inhibition of injury and improvement of survival by such agents, an optimal treatment strategy remains to be developed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available